Total
0
Shares
Oneview Healthcare (ASX:ONE) - CEO, James Fitter (left) and President & Founder, Mark McCloskey (right)
CEO, James Fitter (left) and President & Founder, Mark McCloskey (right)
Source: Silicon Republic
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Oneview Healthcare (ONE) confirms the signing of Northern Health as its first Cloud Start customer in Australia
  • Oneview’s Cloud Start product enables patients to communicate with their clinicians in a covid-safe manner, using its Oneview Care Experience Platform
  • The company’s Cloud Start product will be deployed to Northern Health’s recently completed $162.3 million Stage 2 Inpatient Unit Expansion Project, which became operational in May 2021
  • Oneview Healthcare was up 6.02 per cent, trading at 44 cents at 11:50 am AEST

Oneview Healthcare (ONE) has confirmed the signing of Northern Health as its first Cloud Start customer in Australia.

Northern Health is a provider of acute, maternity and specialist services in Melbourne’s outer north through its four main campuses, Northern Hospital Epping, Broadmeadows Hospital, Bundoora Centre, and Craigieburn Centre, in the area’s fast-growing northern growth corridor.

Oneview’s Cloud Start product will be deployed to Northern Health’s recently completed $162.3 million Stage 2 Inpatient Unit Expansion Project, which became operational in May 2021.

Oneview’s Cloud Start product enables patients to communication with their clinicians in a covid-safe manner, using its Oneview Care Experience Platform.

The platform unifies a facility’s systems, content and services into one digital platform, with dedicated devices at the point of care. In doing so, the company says it delivers more control for patients and their families, more time for care teams, and less complexity for executives and IT teams.

The project is expected to go live in the third quarter of 2021.

Oneview Healthcare is up 4.82 per cent, trading at 43.5 cents at 11:30 am AEST.

ONE by the numbers
More From The Market Herald
Alcidion Group (ASX:ALC) - Group Managing Director, Kate Quirke

" Alcidion (ASX:ALC) to raise $55m & acquire Silverlink

Alcidion (ALC) has announced plans to raise $55 million and buy patient software specialists, Silverlink PCS Software.
Actinogen Medical (ASX:ACW) - CEO & Managing Director, Dr Steven Gourlay

" Actinogen Medical (ASX:ACW) partners with Oxford University

Actinogen (ACW) has announced a collaboration with Oxford University researchers to investigate Xanamem and a condition called mild autonomous cortisol secretion (MACS).
Neuren Pharmaceuticals (ASX:NEU) - CEO, Jon Pilcher

" Neuren Pharmaceuticals (ASX:NEU) soars on ‘positive’ Rett syndrome trial results

Neuren Pharmaceuticals’ (NEU) shares have soared following positive top-line results from a phase three study on Rett syndrome.

" Recce Pharmaceuticals (ASX:RCE) spikes amid trial update

Shares in Recce Pharmaceuticals (RCE) have spiked amid a positive update in the clinical trial for the treatment of burn wound infections.